AR014554A1 - Compuestos polipeptidos, utiles para el tratamiento de infecciones microbianas, procedimiento para prepararlos, composiciones y medicamentos quelos incluyen y el uso de dichos compuestos y metodo para el tratamiento profilactico y terapeutico de infecciones - Google Patents
Compuestos polipeptidos, utiles para el tratamiento de infecciones microbianas, procedimiento para prepararlos, composiciones y medicamentos quelos incluyen y el uso de dichos compuestos y metodo para el tratamiento profilactico y terapeutico de infeccionesInfo
- Publication number
- AR014554A1 AR014554A1 ARP990100549A ARP990100549A AR014554A1 AR 014554 A1 AR014554 A1 AR 014554A1 AR P990100549 A ARP990100549 A AR P990100549A AR P990100549 A ARP990100549 A AR P990100549A AR 014554 A1 AR014554 A1 AR 014554A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- suitable substituent
- alkanoyl
- heterocyclic group
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Se trata de compuestos polipéptidos representados por la formula general (I) donde: R1 es hidrogeno; arilamino alcanoilo (inferior) que puede tener unoo más sustituyente(s) adecuado(s); aroilo sustituido con grupo heterocíclico que puede teneruno o más sustituyente(s) adecuado(s); aroilo sustituido conarilo que tiene alquilo superior, aroilo sustituido con arilo que tiene alquilo inferior: arilo alcanoilo (C2-6) sustituido con arilo que tiene alquiloinferior, alcanoilo inferior sustituidocon grupo heterocíclico condensado no saturado que puede tener uno o más sustituyente(s) adecuado(s); alcanoiloinferior sustituído con piridilo que puede tener uno o más sustituyente(s) adecuado(s) grupo amino protector heptilnaftoilo; hexilnaftoilo, aroilosustituido con carbamoilo heterocíclico que puede tener uno o más sustituyente(s) adecuado(s) alcanoilo inferior sustituido con ciclo alquilo(inferior) que puede tener uno o más sustituyente(s) adecuado(s); alcanoiloinferior sustituido con tienilo que tiene grupo heterocíclico que puede teneruno o más sustituyente(s) adecuado(s); o alquenoilo inferior sustituido con grupo heterocíclico que puede tener uno o más sustituyente(s) adecuado(s); R2es hidrogeno o hidroxi, R3 es hidroxi, hidroxisulfoniloxi o alcoxi inferior. Y R4 es hidroxi o alcoxi inferior, o una de sus sales que tienen actividadesantimicrobianas (especialmente actividades antifungicas), actividad inhibidora sobre la sintasa 1,3 glucan. Seproponen también la preparacion de losmismos y/o composiciones farmacéuticas y métodos para el tratamiento profiláctico o terapéutico de enfermedades infecciosas, incluyendo infeccion dePneumocystis carinil (por ejemplo Pneumocystis carinil pneumonia en seres humanos y animales.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP1728A AUPP172898A0 (en) | 1998-02-09 | 1998-02-09 | New compound |
AUPP3138A AUPP313898A0 (en) | 1998-04-23 | 1998-04-23 | New compound |
Publications (1)
Publication Number | Publication Date |
---|---|
AR014554A1 true AR014554A1 (es) | 2001-02-28 |
Family
ID=25645713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990100549A AR014554A1 (es) | 1998-02-09 | 1999-02-09 | Compuestos polipeptidos, utiles para el tratamiento de infecciones microbianas, procedimiento para prepararlos, composiciones y medicamentos quelos incluyen y el uso de dichos compuestos y metodo para el tratamiento profilactico y terapeutico de infecciones |
Country Status (13)
Country | Link |
---|---|
US (1) | US6232290B1 (es) |
EP (1) | EP1053247A1 (es) |
JP (2) | JP3561917B2 (es) |
KR (1) | KR100396737B1 (es) |
CN (1) | CN1240713C (es) |
AR (1) | AR014554A1 (es) |
BR (1) | BR9907967A (es) |
CA (1) | CA2320416A1 (es) |
HU (1) | HUP0102515A3 (es) |
IL (1) | IL137494A0 (es) |
NO (1) | NO20003996L (es) |
TR (1) | TR200003064T2 (es) |
WO (1) | WO1999040108A1 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE338060T1 (de) * | 1999-03-03 | 2006-09-15 | Lilly Co Eli | Bildung und anionenaustausch von inneren kristallinen ammoniumsalzen des echinocandins b |
AUPP999799A0 (en) | 1999-04-27 | 1999-05-20 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
TWI250992B (en) * | 2000-02-21 | 2006-03-11 | Astellas Pharma Inc | Polypeptide compounds for the prophylactic and/or therapeutic treatment of infectious diseases caused by pathogenic microorganisms |
US7208503B2 (en) * | 2000-04-21 | 2007-04-24 | Janssen Pharmaceutica N.V. | Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
US6316475B1 (en) * | 2000-11-17 | 2001-11-13 | Abbott Laboratories | Aminoalkoxybiphenylcarboxamides as histamine-3 receptor ligands and their therapeutic applications |
AUPR362001A0 (en) * | 2001-03-08 | 2001-04-05 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
AUPS044102A0 (en) * | 2002-02-11 | 2002-03-07 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
AU2003903205A0 (en) * | 2003-06-23 | 2003-07-10 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
AU2003903629A0 (en) * | 2003-07-14 | 2003-07-31 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
EP1799212A2 (en) * | 2004-10-13 | 2007-06-27 | PTC Therapeutics, Inc. | Compounds for nonsense suppression, and methods for their use |
BRPI0612028A2 (pt) * | 2005-06-08 | 2010-10-13 | Novartis Ag | oxadiazóis ou isodiazóis policìclicos e uso dos mesmos como ligantes de receptor s1p |
JP2009501199A (ja) * | 2005-07-12 | 2009-01-15 | グラクソ グループ リミテッド | Gpr38アゴニストとしてのピペラジンヘテロアリール誘導体 |
US20090176837A1 (en) * | 2005-07-12 | 2009-07-09 | Sony Corporation | Compounds with activity at retinoic acid receptors |
US7947707B2 (en) * | 2005-10-07 | 2011-05-24 | Kissei Pharmaceutical Co., Ltd. | Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
CN101516387B (zh) * | 2006-07-26 | 2014-06-04 | 桑多斯股份公司 | 卡泊芬净制剂 |
CA2884347C (en) | 2007-08-13 | 2019-10-15 | Monsanto Technology Llc | Methods for the control of plant parasitic nematodes comprising application of oxadiazole compounds to plants, seeds or soil |
BRPI0820409A2 (pt) | 2007-10-29 | 2015-05-19 | Astellas Pharma Inc | Composto de polipeptídeo |
JP5387567B2 (ja) | 2008-03-14 | 2014-01-15 | アステラス製薬株式会社 | 環状化合物およびその塩 |
WO2010081851A1 (en) | 2009-01-14 | 2010-07-22 | Genoscience Pharma | Piperidin-4-ylpiperazine compounds for the treatment of hcv infection |
WO2010131691A1 (ja) * | 2009-05-14 | 2010-11-18 | アステラス製薬株式会社 | ポリケチド化合物 |
US9353072B2 (en) * | 2012-10-31 | 2016-05-31 | Purdue Research Foundation | Antimicrobial substituted thiazoles and methods of use |
WO2019207413A1 (en) | 2018-04-25 | 2019-10-31 | Universidad De La República (Udelar) | Cyclic hexapeptides compounds with anti-malarial activity |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL98506A (en) | 1990-06-18 | 1996-09-12 | Fujisawa Pharmaceutical Co | Peptides, of antibiotics, processes for their preparation and pharmaceutical preparations containing them |
US5965525A (en) * | 1992-03-19 | 1999-10-12 | Eli Lilly And Company | Cyclic peptide antifungal agents |
AU681119B2 (en) * | 1993-05-17 | 1997-08-21 | Fujisawa Pharmaceutical Co., Ltd. | New polypeptide compound and a process for preparation thereof |
US6107458A (en) * | 1994-10-07 | 2000-08-22 | Fujisawa Pharmaceutical Co., Ltd. | Cyclic hexapeptides having antibiotic activity |
US5629289A (en) * | 1995-07-25 | 1997-05-13 | Eli Lilly And Company | Cyclic peptide antifungal agents |
-
1999
- 1999-02-05 CA CA002320416A patent/CA2320416A1/en not_active Abandoned
- 1999-02-05 IL IL13749499A patent/IL137494A0/xx unknown
- 1999-02-05 TR TR2000/03064T patent/TR200003064T2/xx unknown
- 1999-02-05 CN CNB998049018A patent/CN1240713C/zh not_active Expired - Fee Related
- 1999-02-05 HU HU0102515A patent/HUP0102515A3/hu unknown
- 1999-02-05 WO PCT/JP1999/000538 patent/WO1999040108A1/en not_active Application Discontinuation
- 1999-02-05 EP EP99902855A patent/EP1053247A1/en not_active Withdrawn
- 1999-02-05 KR KR10-1999-7012552A patent/KR100396737B1/ko not_active IP Right Cessation
- 1999-02-05 JP JP54028799A patent/JP3561917B2/ja not_active Expired - Fee Related
- 1999-02-05 US US09/446,101 patent/US6232290B1/en not_active Expired - Fee Related
- 1999-02-05 BR BR9907967-4A patent/BR9907967A/pt not_active IP Right Cessation
- 1999-02-09 AR ARP990100549A patent/AR014554A1/es unknown
-
2000
- 2000-08-08 NO NO20003996A patent/NO20003996L/no not_active Application Discontinuation
-
2003
- 2003-09-12 JP JP2003322336A patent/JP2004067699A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP3561917B2 (ja) | 2004-09-08 |
HUP0102515A3 (en) | 2001-12-28 |
CN1296494A (zh) | 2001-05-23 |
IL137494A0 (en) | 2001-07-24 |
NO20003996L (no) | 2000-10-09 |
TR200003064T2 (tr) | 2001-02-21 |
BR9907967A (pt) | 2000-10-17 |
NO20003996D0 (no) | 2000-08-08 |
US6232290B1 (en) | 2001-05-15 |
JP2004067699A (ja) | 2004-03-04 |
CN1240713C (zh) | 2006-02-08 |
WO1999040108A1 (en) | 1999-08-12 |
JP2001522377A (ja) | 2001-11-13 |
CA2320416A1 (en) | 1999-08-12 |
KR100396737B1 (ko) | 2003-09-13 |
EP1053247A1 (en) | 2000-11-22 |
HUP0102515A2 (hu) | 2001-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR014554A1 (es) | Compuestos polipeptidos, utiles para el tratamiento de infecciones microbianas, procedimiento para prepararlos, composiciones y medicamentos quelos incluyen y el uso de dichos compuestos y metodo para el tratamiento profilactico y terapeutico de infecciones | |
CY1110914T1 (el) | Δικυκλο-πυραζολες δραστικες ως αναστολεις kinασων, διεργασια για την παρασκευη τους και φαρμακευτικες συνθεσεις που τις περιλαμβανουν | |
DE69529670T2 (de) | Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen | |
MXPA04012965A (es) | Inhibidores virales. | |
MX2007004783A (es) | Inhibidores de la proteasa del virus de la hepatitis c, y composiciones y tratamientos que los usan. | |
ID21526A (id) | 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus | |
BR0113039A (pt) | Composto ou um seu sal ou solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um indivìduo humano ou animal com uma condição antiinflamatória e/ou alérgica, e, processo para preparar um composto | |
BR0116216A (pt) | Inibidores de girase e seus usos | |
DK2314582T3 (da) | Heterocykliske forbindelser som antivirusmidler | |
BR0010476A (pt) | Compostos derivados do 4,5,6,7-tetrahidroindazol e seu uso como agentes antitumorais | |
BRPI0416752A (pt) | composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica | |
PA8456901A1 (es) | 2-aminopiridinas que contienen sustituyentes de anillos condensados | |
BR0210122A (pt) | Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo | |
EA199901014A1 (ru) | C-4"-замещенные макролидные производные | |
BR0016605A (pt) | Oxazolidinonas possuindo uma funcionalidade sulfoximina e seus usos como agente antimicrobiano | |
TR200201205T2 (tr) | N-ikame edilmiş karbamoiloksialkil-azolyum türevleri. | |
HUP0101817A2 (hu) | 15 tagú laktám ketolidok és ezeket tartalmazó antibakteriális hatású gyógyszerkészítmények | |
DK0992509T3 (da) | Nye makrolid-derivater | |
BR0314352A (pt) | Indóis 2,7-substituìdos e seu uso como moduladores de 5-ht6 | |
BR0309878A (pt) | Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase | |
DE69931378D1 (de) | Chinazolin derivate und therapeutische verwendungen davon | |
BR0207102A (pt) | Forma cristalina, composição farmacêutica, uso de uma forma cristalina, e, método para a prevenção ou o tratamento de doença | |
PT916670E (pt) | Pirrolo-(3,2-b) piridinas e o seu uso como agonistas do 5-ht1f | |
IT1216104B (it) | Peptidi ad attivita' farmaceutica. | |
BR0108002A (pt) | Derivados de amidas heterocìclicas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |